# Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

> **NCT01607658** · PHASE2 · COMPLETED · sponsor: **Acerus Pharmaceuticals Corporation** · enrollment: 253 (actual)

## Conditions studied

- Female Orgasmic Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** Low dose TBS-2
- **DRUG:** Medium dose TBS-2
- **DRUG:** High dose TBS-2

## Key facts

- **NCT ID:** NCT01607658
- **Lead sponsor:** Acerus Pharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607658, "Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01607658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*